They may adjust your dose or recommend strategies to manage symptoms
With the help of the various processes described in this blog post, the rapid reduction in body fat one may see should provide a strong motivational basis to initiate more sensible food intake patterns
A large share of the early telehealth weight loss boom was built on compounded semaglutide and tirzepatide, which pharmacies were temporarily allowed to make while the branded drugs were on the FDA's shortage list
The question behind the question is usually: "How much longer will I be able to get compounded semaglutide at this price?" The pattern we see: patients conflate three separate timelines: Patent expiration (2031-2033 for the formulations that matter) FDA shortage list removal (expected late 2026 to Q1 2027) Generic market entry (2027 for oral, 2031-2032 for injectable, assuming no patent challenges) The timeline that affects current compounded access is number 2, not number 1
55 mg NEXTIDA GC Collagen Peptides (Bovine)
Implications for employers: The White House press release and news reports remain vague about pricing for employer sponsored health plans - so employers should watch closely to see the impact on their acquisition costs
